Quantitative BCR/ABL Molecular Detection
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms |
p190 BCR/ABL-QN p210 HLX BCR-ABL by RT-PCR CASE t(9;22) major by quantitative RT-PCR Quantitative RT-PCR, CML or ALL |
| Cerner Primary Mnemonic | HLX BCR-ABL by RT-PCR CASE |
| EPIC Display Name | Quantitative BCR/ABL Molecular Detection |
| Allscripts (AEHR) Order Name | BCR/ABL Quantitative |
| Sunrise Clinical Manager (SCM) Order Name | Not Orderable |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results | |
| Clinical Info |
CML is a myeloproliferative disorder characterized by the presence of the Philadelphia (Ph) chromosome. This chromosome is the product of t (9; 22), a reciprocal translocation between the long arms of chromosomes 9 and 22. The corresponding fusion gene, BCR-ABL1, is transcribed into an 8.5 KB mRNA, with 2 junction variants b2a2 (40% of cases) and b3a2 (55% of cases). The b2a3 and b3a3 transcripts represent less than 5% of cases. The fusion gene encodes for a chimeric protein, p210, with elevated tyrosine kinase activity. |
| Specimen Type |
Blood, Bone Marrow |
| Container |
Lavender Top Tube |
| Collection Instructions |
Peripheral Blood or Bone Marrow Container/Tube: Lavender-top (EDTA) tube(s) Specimen: 1-3 ml collected in EDTA (lavender top tubes). Transport Temperature: Refrigerated Collection Instructions: Specimens should be stored in the refrigerator at 4ºC. Specimens should be processed within 3 days. |
| Transport Instructions |
Refrigerated |
| Specimen Stability |
3 days Refrigerated |
| Methodology |
Real-Time Polymerase Chain Reaction (PCR) |
| Days Performed |
Monday through Friday TAT: 8 Calendar days |
| Performing Laboratory |
Northwell Health Laboratories |
| CPT |
83891 - DNA extract-purify 83898 x 2 - amplification 83902 - reverse transcription |
| PDM |
5911120 |
Desired Epic Build Quantitative BCR/ABL Molecular Detection
| Cerner Primary Mnemonic: | HLX BCR-ABL by RT-PCR CASE |
| PDM | 5911120 |
| Informatics - Workgroup | Molpath inhouse |
| Synonyms * | p190 BCR/ABL-QN p210 HLX BCR-ABL by RT-PCR CASE t(9;22) major by quantitative RT-PCR Quantitative RT-PCR, CML or ALL |
| Display Name * | Quantitative BCR/ABL Molecular Detection |
| Order Entry Specimen Sources * | |
| Order Entry Specimen Types |
Aspirate
|
| Specimen Navigator Specimen Types | |
| Specimen Navigator Specimen Sources | |
| Specimen Navigator Short Name | |
| Ordering info (EPIC SmartText) | CML is a myeloproliferative disorder characterized by the presence of the Philadelphia (Ph) chromosome. This chromosome is the product of t (9; 22), a reciprocal translocation between the long arms of chromosomes 9 and 22. The corresponding fusion gene, BCR-ABL1, is transcribed into an 8.5 KB mRNA, with 2 junction variants b2a2 (40% of cases) and b3a2 (55% of cases). The b2a3 and b3a3 transcripts represent less than 5% of cases. The fusion gene encodes for a chimeric protein, p210, with elevated tyrosine kinase activity. |
| IP Orderable | Yes |
| OP Orderable | Yes |
|
AOEs * | |
| AP AOEs | |
| Special History | Yes |
| Build Comments | |
| Filter * | genetics |
| Procedure Category Change | |
| Cerner Results | |
Current Actual EPIC Build as of 10/28/2024
| Procedure Id | 115137 | ||||||||||||||||||||||||
| Pdm | 5911120 | ||||||||||||||||||||||||
| Order Display Name | Quantitative BCR/ABL Molecular Detection | ||||||||||||||||||||||||
| Procedure Name | BCR/ABL BY RT - PCR QUANTITATIVE | ||||||||||||||||||||||||
| Procedure Master Number | LAB11398 | ||||||||||||||||||||||||
| Short Procedure Name | BCR/ABL BY RT - PCR QUANTITATIVE | ||||||||||||||||||||||||
| Category Code | 21.0 | ||||||||||||||||||||||||
| Category Code Record Name | LAB MOLECULAR DIAGNOSTICS ORDERABLES | ||||||||||||||||||||||||
| Synonyms | P190 BCR/ABL-QN P210 HLX BCR-ABL BY RT-PCR CASE T(9;22) MAJOR BY QUANTITATIVE RT-PCR QUANTITATIVE RT-PCR, CML OR ALL | ||||||||||||||||||||||||
| Clinically Active | Yes | ||||||||||||||||||||||||
| Orderable | Yes | ||||||||||||||||||||||||
| Performable | Yes | ||||||||||||||||||||||||
| Filter Genomics | Generic Genomics Procedure | ||||||||||||||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/115137 | ||||||||||||||||||||||||
| Ordering Instructions | |||||||||||||||||||||||||
| Default Specimen Type | Blood | ||||||||||||||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||||||||||||||
| Specimen Type List | |||||||||||||||||||||||||
| Op Specimen Type List | |||||||||||||||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||||||||||||||
| Specimen Source List | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary | ||||||||||||||||||||||||
| Op Specimen Source List | |||||||||||||||||||||||||
| Ip Lab Test Components For Report | HLXBCR:10 | ||||||||||||||||||||||||
| Op Lab Test Components For Report | HLXBCR:10 | ||||||||||||||||||||||||
| Order Questions | ["3045300170", "3045300171", "3045300173"] | ||||||||||||||||||||||||
| Order Questions Record Name | NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY | ||||||||||||||||||||||||
| Inpatient Order Questions | ["3048500000"] | ||||||||||||||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||||||||||||||
| Order Specific Question Override | Yes | ||||||||||||||||||||||||
| Inpatient Question Override | |||||||||||||||||||||||||
| Location Restrict List Ip | |||||||||||||||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||||||||||||||
| Location Restrict List Include Ip | |||||||||||||||||||||||||
| Location Restrict List Op | |||||||||||||||||||||||||
| Location Restrict List Op Record Name | |||||||||||||||||||||||||
| Location Restrict List Includes Op | |||||||||||||||||||||||||
| Edp Amb Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||||||||||||||
| Edp Ip Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||||||||||||||
| Edp Ip Specimen Source | |||||||||||||||||||||||||
| Edp Op Specimen Source | |||||||||||||||||||||||||
| Edp Ip Specimen Type | |||||||||||||||||||||||||
| Edp Op Specimen Type | |||||||||||||||||||||||||
| Derived Edp Ip Buttons S | |||||||||||||||||||||||||
| Derived Edp Ip Buttons T | |||||||||||||||||||||||||
| Derived Edp Op Buttons S | |||||||||||||||||||||||||
| Derived Edp Op Buttons T | |||||||||||||||||||||||||
| Ip Orderable | 1 | ||||||||||||||||||||||||
| Op Orderable | 1 | ||||||||||||||||||||||||
EPIC OP AOEs
| |||||||||||||||||||||||||
EPIC IP AOEs
| |||||||||||||||||||||||||
| EPIC Components (results) | |||||||||||||||||||||||||